Joseph G. Pressey · "From Drowning to Treading Water": Adolescents and Young Adults Living with Incurable and Indolent Metastatic Soft Tissue Sarcoma for More than Two Years
Follow
Article1 min read·Published Jan 2025

"From Drowning to Treading Water": Adolescents and Young Adults Living with Incurable and Indolent Metastatic Soft Tissue Sarcoma for More than Two Years

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2025 · 1 min read

In brief

In brief

This pilot study examines the clinical characteristics and lived experiences of adolescents and young adults with incurable metastatic soft tissue sarcoma who survived beyond two years. Using PROMIS questionnaires and qualitative analysis, researchers explore quality of life and develop a conceptual framework for understanding long-term survival in this rare population.

Written by the GCMD Library team from the article.

Joseph G. Pressey

Introduction: Adolescent/young adult (AYA) patients with metastatic soft tissue sarcoma (STS) typically face a dismal prognosis. However, a subset of patients with incurable disease lives beyond two years. Due to the rarity of diagnoses and inherent heterogeneity within this population, a paucity of data exists regarding the experiences of AYAs with an indolent course (and how to best capture these experiences). With increasing biological insight and clinical experience, including the use of targeted or immune therapies, it is anticipated that more such patients will experience prolonged survival. Our pilot study aimed to describe the clinical characteristics and illness experiences of AYAs with incurable yet indolent metastatic STS who were living two years after their diagnoses. Our exploratory aim was to generate a conceptual framework that could subsequently be tested in a multi-center study with a larger cohort of patients. Materials And Methods: Patients with metastatic incurable STS, aged 15-39 years at diagnosis, and at least two years from diagnosis, were eligible. Patients were recruited over a two-year period at a quaternary children's hospital with a comprehensive AYA oncology program. Participants completed a demographic form and PROMIS short form questionnaires for seven domains and answered an open-ended question. Responses to open-ended questions were coded independently by two authors and utilized to generate themes. Clinical variables were collected from med

Statements in this article

  1. Adolescent and young adult patients with metastatic soft tissue sarcoma typically face a dismal prognosis.

    EstablishedIntroduction
  2. A subset of patients with incurable metastatic soft tissue sarcoma lives beyond two years.

    EstablishedIntroduction
  3. More patients with metastatic soft tissue sarcoma are anticipated to experience prolonged survival with the use of targeted or immune therapies.

    EstablishedIntroduction
  4. Patients with metastatic incurable soft tissue sarcoma, aged 15-39 years at diagnosis, and at least two years from diagnosis were eligible for this study.

    ResearchMaterials And Methods
  5. Patients were recruited over a two-year period at a quaternary children's hospital with a comprehensive adolescent and young adult oncology program.

    ResearchMaterials And Methods

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.